https://www.managedcaremag.com/. /judge-rules-sanofi-regeneron-s-pcsk9- cannot-be-sold-us-saying-it-infringes-amgenCachedJan 6, 2017 . Sanofi SA and Regeneron Pharmaceuticals, who partnered to make a new

https://globenewswire.com/. /Sanofi-and-Regeneron-Announce-Praluent- alirocumab-Cardiovascular-Outcomes-Trial-will-Continue-as-Planne. CachedNov 17, 2016 . Sanofi and Regeneron Announce Praluent® (alirocumab) . Effect of alirocumab,

seekingalpha.com/. /3233317-amgen-prevails-sanofi-regeneron-pcsk9- patent-caseCachedJan 4, 2017 . Sanofi (SNY) and Regeneron Pharmaceuticals (REGN) lose their bid to overturn

www.pharmatimes.com/. /sanofiregenerons_praluent_first_us-approved_ pcsk9_inhibitor_971705CachedJul 26, 2015 . US regulators have approved Sanofi and Regeneron's PCSK9 inhibitor Praluent

www.pmlive.com/. /amgen_wins_block_on_sales_of_sanofiregenerons_ praluent_1183459CachedJan 6, 2017 . Amgen has won another round in its lawsuit with Sanofi and Regeneron over

www.law360.com/. /sanofi-wants-jury-verdict-axed-in-amgen-drug-patent- rowCachedMay 24, 2016 . Sanofi SA and Regeneron Pharmaceuticals Inc. argued the court . gene] PCSK9

www.marketwatch.com/. /judges-unusual-ruling-on-amgen-regeneron-patent -case-puts-billions-of-dollars-at-stake-2017-01-06Jan 7, 2017 . The decision could force Regeneron/Sanofi to stop selling their $14000-a-year .

www.medpagetoday.com/cardiology/dyslipidemia/62421CachedJan 9, 2017 . After a U.S. District Court judge issued an injunction late last week barring the

www.biopharmadive.com/news/amgen. ban. regeneron/433523/CachedJan 6, 2017 . Amgen on Thursday won a major legal victory in its patent battle with Sanofi and

en.sanofi.com/partners/. /commercial_collaboration.aspxCachedSimilarUsing Regeneron's innovative Veloclmmune technology, Sanofi developed

blogs.sciencemag.org/pipeline/archives/2017/01/06/12104CachedJan 6, 2017 . Sanofi and Regeneron tried to get that verdict overturned, but on . When it

www.cardiovascularbusiness.com/. /judge-rules-sanofi-regeneron-cannot-sell -pcsk9-inhibitor-usCachedJan 6, 2017 . 5 that Sanofi and Regeneron Pharmaceuticals could not market or sell their

www.crtonline.org/. /amgen-wins-patent-case-its-repatha-pcsk9-against-sCachedAmgen Wins Patent Case for Its Repatha PCSK9 Against Sanofi and

https://www.regeneron.com/node/793CachedALIROCUMAB*. Drug Description: PCSK9 Antibody. Target Condition: LDL

https://en.wikipedia.org/wiki/PCSK9CachedSimilarProprotein convertase subtilisin/kexin type 9 (PCSK9) is an enzyme encoded by

www.fiercepharma.com/. /amgen-claims-sanofi-regeneron-resort-to- hyperbole-scare-tactics-pcsk9-appealCachedFeb 1, 2017 . Amgen has kicked back at Sanofi and Regeneron's attempt to keep . in a

www.investopedia.com/. /judge-blocks-regeneron-cholesterol-drug-regn/CachedJan 6, 2017 . U.S.-based Regeneron and France-based Sanofi jointly developed the

https://en.wikipedia.org/wiki/AlirocumabCachedSimilarAlirocumab (trade name Praluent) is a biopharmaceutical drug approved by the

www.pharmacytimes.com/news/judge-hands-pcsk9-victory-to-amgenCachedJan 6, 2017 . A United States District Court judge in Delaware granted Amgen's request for a

www.epresspack.net/mmr/sanofi-pcsk9-1st-phase3-results/CachedSimilarOct 16, 2013 . Sanofi and Regeneron Report Positive Top-line Results with Alirocumab from

www.fiercepharma.com/. /amgen-sanofi-and-regeneron-trot-out-new-pcsk9- data-at-european-heart-meetingCachedAug 29, 2016 . Amgen, Sanofi and Regeneron are awaiting much-anticipated outcomes data on

finance.yahoo.com/. /blog-coverage-amgens-legal-victory-131500477.htmlCachedJan 9, 2017 . Amgen had filed the lawsuit against Sanofi and Regeneron in October 2014.

https://www.zacks.com/. /amgen-wins-pcsk9-lawsuit-sanofi-and-regeneron- to-appealCachedMar 17, 2016 . Amgen (AMGN) received a favorable ruling in its patent infringement lawsuit for

www.mabspacebio.com/news_detail/newsId=10.htmlCachedJan 7, 2017 . Amgen's Repatha and Sanofi/Regeneron's Praluent are competing for market

www.fiercebiotech.com/topic/pcsk9-drugsCachedHere's the most recent news related to PCSK9 drugs. . Regeneron rises on

https://www.drugs.com/. /pcsk9-inhibitors-a-new-option-in-cholesterol- treatment-1166CachedJan 12, 2017 . PCSK9 inhibitors, a newer class of cholesterol-lowering drugs, show . (Praluent)

www.ipwatchdog.com/2017/01/17/. regeneron. pcsk9. /id=76924/CachedJan 17, 2017 . Amgen v. Regeneron. The Delaware district court recently .

www.tctmd.com/. /alirocumab-remain-market-while-companies-clash-over- patentsCachedFeb 9, 2017 . Regeneron and Sanofi, who have partnered to manufacture, market, and .

www.ajmc.com/. /praluent-to--stay-on-market-as-pcsk9-patent-war- continues-in-courtCachedFeb 10, 2017 . Praluent to Stay on Market as PCSK9 Patent War Continues in Court . In March

www.mdmag.com/medical. /judge-hands-pcsk-9-victory-to-amgenCachedJan 6, 2017 . At issue was whether Regeneron violated Amgen's patents. Both entities make a

https://www.thestreet.com/. /regeneron-cholesterol-lowering-drug-banned- from-u-s-market-in-stunning-loss-to-amgen-in-patent-case.htmlCachedJan 6, 2017 . . a class of cholesterol-lowering drugs known as PCSK9 inhibitors. Regeneron

https://www.statnews.com/. /sanofi-regeneron-cholesterol-amgen/CachedMar 23, 2016 . A cholesterol drug from Sanofi and Regeneron could be taken off the . Both

https://www.fool.com/. /why-biotech-titans-are-clashing-over-cholesterol. aspxCachedJan 8, 2017 . Amgen's Repatha and Sanofi and Regeneron's Praluent are PCSK9 inhibitors,

https://www.streetinsider.com/. Regeneron. /11738048.htmlCachedJun 14, 2016 . Sanofi and Regeneron further argue the single Repatha dose could . In spite of

www.fiercepharma.com/. /judge-upholds-pcsk9-patent-ruling-amgen-s-favor -as-sanofi-regeneron-get-set-to-appealCachedJan 4, 2017 . Back in March, a Delaware jury ruled that Sanofi and Regeneron's PCSK9

www.forbes.com/. /amgen-regeneron-stocks-go-up-as-drugs-bring- cholesterol-down/CachedSimilarMar 16, 2015 . Ask people at Amgen and Regeneron Pharmaceuticals how they plan to . drugs

https://www.pharmpro.com/. /sanofi-and-regeneron-appeal-court-rulings- praluent-patent-litigationCachedJan 6, 2017 . Regeneron and Sanofi to appeal U.S. District Court rulings in ongoing . a

www.investors.com/. /amgens-ldl-buster-ramps-the-medicines-co-but- regeneron-slides/CachedFeb 3, 2017 . LDL-busters from Amgen and Regeneron/Sanofi belong to a class of drugs

www.fiercebiotech.com/. /updated-amgen-beats-regeneron-sanofi-to-world-s -first-big-pcsk9-drug-okCachedJul 21, 2015 . Amgen may be running a beat or two behind Regeneron and Sanofi in search of

www.xconomy.com/. /regeneron-its-still-wait-until-2017-for-big-heart-drug- study/CachedNov 17, 2016 . The massive, 18,000 patient study is testing whether Regeneron's PCSK9

https://cholesterolmatters.com/en/what-is-pcsk9.htmlCachedSimilarWatch a video depicting the PCSK9 pathway, and how PCSK9 regulates . of

https://www.acc.org/. / ESC15%20TUES%209AM%20ET%20Presentation%20Slides%20O. CachedSimilarEfficacy and Safety of the PCSK9 Monoclonal Antibody Alirocumab versus

https://www.benzinga.com/. /catalyst-alert-amgenregeneron-patent-case- appeal-could-bCachedJan 10, 2017 . Catalyst Alert: Amgen/Regeneron Patent Case Appeal Could Be Decided . over

https://endpts.com/no-early-success-for-regeneron-sanofi-in-phiii-outcomes- study-for-praluent/CachedNov 17, 2016 . The companies noted early today that they will have to go all the way to the end

www.fiercepharma.com/. /sorry-praluent-sanofi-regeneron-s-pcsk9-med- misses-boat-early-outcomes-data-boostCachedNov 17, 2016 . Sanofi and Regeneron's cholesterol-fighter Praluent might have had a chance to

www.biopharminternational.com/regeneron-and-sanofi-ordered-withdraw- pcsk9-inhibitor-praluent-market-0CachedJan 6, 2017 . A federal judge ruled on Jan. 5, 2016 that Regeneron and Sanofi must pull the

www.news.sanofi.us/Sanofi-and-Regeneron-Strongly-Disagree-with-U-S-Jury -Verdict-in-Ongoing-Patent-Litigation-Regarding-Praluent-alirocum. CachedMar 16, 2016 . Sanofi and Regeneron believe these Amgen patent claims are invalid . In July

www.reuters.com/article/us-sanofi-fr-amgen-idUSKBN14N1VDCachedJan 3, 2017 . Sanofi, Regeneron lose bid to overturn Amgen win in patent case . to lower bad

https://www.firstwordpharma.com/node/1450801CachedFeb 9, 2017 . Amgen claimed that Praluent infringed two patents covering its own PCSK9

https://www.bloomberg.com/. /amgen-wins-ban-on-sanofi-s-sales-of- praluent-cholesterol-drugCachedJan 5, 2017 . Amgen Inc. won a court ruling blocking rivals Sanofi and Regeneron . Repatha

Sitemap